Jump to Main Contents
先端医療開発センター

Home > Organization > Division of Cancer Immunotherapy (Kashiwa)

Group for Innovative Cancer TreatmentDivision of Cancer Immunotherapy (Kashiwa)

News

Jul. 13, 2020
We had a farewell ceremony for Toshiaki Yoshikawa
Jul. 13, 2020
Toshiaki Yoshikawa, belonged in our labo. for 13 years, has transferred to the Division of Immune Response, Aichi Cancer Center Research Institute as a Researcher. (He will continue to be a Visiting Researcher in our labo.)
Jul. 1, 2020
Update Members
Jun. 11, 2020
Update Publication list
Jun. 11, 2020
Update Members
Jan. 16, 2020
Update member list and Publication list.
Jul. 18, 2019
Our article, Cancer immunotherapy-targeted glypican-3 or neoantigens, published in Cancer Science, is one of the journal's top downloaded recent papers!Amongst articles published between January 2017 and December 2018, our paper received some of the most downloads in the 12 months following online publication.
Jul. 17, 2019
Update member list and Publication list.